Department of Hematology and Oncology, Charité, Berlin, Germany.
Experimental and Clinical Research Center, Charité and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
Cancer Treat Rev. 2017 Apr;55:36-45. doi: 10.1016/j.ctrv.2017.02.009. Epub 2017 Mar 6.
Through the introduction of a steadily growing variety of preclinical test models drug development and biomarker research has advanced. Next to classical used 2D cell line cultures, tissue-slice cultures, 3D organoid cell cultures, genetically engineered mouse models, cell line derived mouse models and patient derived xenografts may be selected for a specific question. All models harbor advantages and disadvantages. This review focuses on the available preclinical test models, novel developments such as humanized mice and discusses for which question a particular model should be employed.
通过引入不断增加的各种临床前测试模型,药物开发和生物标志物研究取得了进展。除了经典的 2D 细胞系培养、组织切片培养、3D 类器官细胞培养、基因工程小鼠模型、细胞系衍生的小鼠模型和患者来源的异种移植物外,还可以针对特定问题选择特定的模型。所有模型都有优点和缺点。本文重点介绍现有的临床前测试模型、新型模型如人源化小鼠,并讨论对于特定问题应采用哪种模型。